Two strategies for the enantioselective synthesis of some isoxazolidinyl nucleosides, as potential antiviral drugs, are reported. In particular, a one-step approach based on 1,3-dipolar cycloaddition with vinyl nucleobases and a two-step methodology based on the Vorbrüggen nucleosidation have been exploited in the preparation of 4'-aza-2',3'-dideoxynucleoside analogues containing uracil, 5-fluorouracil, thymine and cytosine.
Introduction
Derivatives of natural nucleic acids play an important role in current chemotherapy as potent and selective antiviral agents in AIDS therapy. 1 A series of new compounds, endowed with relevant biological activity, originate from chemical modifications of the nucleic acid fragments at the level of the sugar moiety and/or the heterocyclic base. In this context, the design of novel "ribose" rings has resulted in the discovery of effective biological agents; promising results have been obtained from a new generation of nucleoside analogues where the furanose ring has been replaced by an alternative carbo-or heterocyclic ring. 2 In particular, isoxazolidinyl nucleosides have been synthesized recently in order to investigate their pharmacological activities. As an extension of our ongoing work on the synthesis of isoxazolidinyl analogues having potential antiretroviral effectiveness, 6 in this paper we exploit the use of a series of vinyl nucleobases in order to prepare 4'-aza-2',3'-dideoxyfuranosyl nucleosides through the 1,3-dipolar cycloaddition methodology. Nitrones containing a chiral auxiliary on the nitrogen atom have been selected as the most convenient precursors for a one-pot reaction pathway towards enantiomerically pure pyrimidine N,O-nucleosides. The reaction of ribosyl hydroxylamine 2 with formaldehyde and the vinylic bases 4 was performed in CHCl 3 at 60°C for 12 h to give, through the intermediate unisolated nitrone 3, a mixture of two homochiral isoxazolidines 5 and 6, epimeric at C 5' , in a relative ratio 1.5:1 (40% yield) (Scheme 1).
The stereochemistry assigned to the obtained adducts is supported by NMR analyses. In fact, NOE measurements performed on 5a-d and 6a-d show a positive NOE effect for protons 4" when irradiating 1", thus indicating a cis-relationship between these protons. These data confirm that the sugar moiety has a β− configuration in both nucleosides.
Mixtures of diastereomeric invertomers could be observed for compounds 5 and 6. Variabletemperature NMR measurements were performed. Upon lowering of the temperature to -80 °C, it was not possible to reveal the presence of two frozen forms, so suggesting the existence of only one isomer, or a nitrogen inversion sufficiently fast to impart time-averaged properties to the observed compounds. PM3 7 quantum-mechanical calculations allow for a clear rationalization of the obtained results. Structural analyses regarding the stabilities of the formed isomers indicate that the N 2' -C 5' trans-isomers are more stable than the cis-derivatives. An energy difference of 4.3 kcal/mol
The marked preference for the trans-form makes these compounds analogues of α-nucleosides. Thus, for the α− and β− anomers obtained, the difference in configuration of their C 5' atoms is compensated by the nitrogen inversion, and both anomers possess the same trans-disposition of their N 2' -and C 5' -substituents.
Scheme 1
On this basis, and according to the quantum-mechanical calculations, the relative configuration at N 2' and C 5' for nucleosides 5 and 6 has been assigned as reported in Scheme 1. The major stereoisomers 5a-d can be assigned the configuration (5'R) which is more stable than the configuration (5'S) by about 0.8 kcal/mol: this value is in agreement with the observed α/β ratio. The initial goal of the design of a synthetic approach towards the homochiral N,Onucleosides 7 and 8 has been reached by selective cleavage of the sugar moiety, performed by treatment with 1.5% aqueous HCl (Scheme 2). Thus, both anomers 7a-d and 8a-d have been obtained with a global yield of 30% and 10% respectively, starting from the nitrone 3.
Our previously reported synthetic approach to enantiomerically pure isoxazolidinyl nucleosides 7b,c and 8b,c develops in two steps and includes the cycloaddition of the transient nitrone 3 with vinyl acetate followed by the coupling with silylated nucleobases.
We have compared two procedures: thus, the ribosyl hydroxylamine 2 was reacted with formaldehyde and vinyl acetate to give a mixture of two homochiral isoxazolidines 9 and 10, epimeric at C 5 , in a relative ratio 1.5:1 (90% yield). 5 The subsequent coupling with silylated uracil 11a, selected as a model compound, in acetonitrile in the presence of TMSOTf at 0°C, occurs with 80% yield and affords, in a 1.4:1 ratio, the expected nucleosides 5a and 6a, which have been separated by flash chromatography and then by HPLC (Scheme 3). The reaction pathway shows a global yield of 72%. Scheme 3
Conclusions
Enantiomers of 4'-aza-2',3'-dideoxynucleosides have been prepared by two different synthetic approaches. The results show that the two-step procedure, based on the 1,3-dipolar cycloaddition of the chiral nitrone 4 with vinyl acetate and the subsequent Vorbrüggen nucleosidation, leads to clearly better yields. Biological evaluation of the obtained compounds is in progress. Preliminary data are encouraging: for ADF, tests have been performed on four different cell lines of lymphoid and monocytoid cells. The obtained data indicate that ADF is a good inducer of cell death by apoptosis on Molt-3 cells: at a dose of 128 µM, this compound causes apoptosis on 50% of the examined cells. A suspension containing the vinylic base 4a-d (1 eq.), ribosyl hydroxylamine 2 (1 eq.) and formaldehyde (1 eq.) in chloroform (10 mL) was heated in a sealed vessel at 60 °C under stirring, until the hydroxylamine was consumed (7-8 h) . After this time, 0.5 eq. of hydroxylamine and formaldehyde were added and the mixture was left to react for an additional 4 h. Removal of the solvent in vacuum affords a crude material which was purified by flash chromatography to give a mixture of the homochiral isoxazolidines 5a-d and 6a-d, which after separation by HPLC (2-propanol-n-hexane) show the physical and spectroscopic data listed below.
Method B. General procedure for the reaction between silylated bases 11a,d and isoxazolidines 9, 10 A suspension of the base 5a,d (0.62 mmol) in dry acetonitrile (3 mL) was treated with bis(trimethylsilyl)acetamide (2.54 mmol) and heated under reflux for 15 min with stirring. The clear solution obtained was treated with a solution of the epimeric isoxazolidines 9 or 10 5 (0.52 mmol) in dry acetonitrile (3 mL), trimethylsilyl triflate (0.78 mmol) was added dropwise, and the reaction mixture heated under reflux for 1 h. After cooling at 0 °C, the solution was neutralized by careful addition of aqueous 5% sodium bicarbonate, and then concentrated in vacuo. After addition of dichloromethane (8 mL 38, 26.78, 27.17, 37.10, 48.15, 64.08, 81.23, 82.77, 84.33, 85.98, 99.02, 102.16, 113.38, 127.75, 127.77, 129.85, 129.85, 129.91, 133.13, 133.20, 135.56, 139.99, 149.91, 163 .00.
5'S)-1-{2-[6-(tert-Butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl]-isoxazolidin-5-yl}-1H-pyrimidine-2,4-dione (6a

(5′R)-1-{2-[6-(tert-Butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-tetrahydro-furo-[3,4-d][1,3]dioxol-4-yl]-isoxazolidin-5-yl}-5-fluoro-1H-pyrimidine-2,4-dione (5b). Yield 23% (Method A), 46% (Method B)
. 5 Physical and spectroscopic data are identical to those reported previously.
(5′S)-1-{2-[6-(tert-Butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-tetrahydro-furo-[3,4-d][1,3]-dioxol-4-yl]-isoxazolidin-5-yl}-5-fluoro-1H-pyrimidine-2,4-dione (6b).
Yield 17% (Method A), 26% (Method B). 5 Physical and spectroscopic data are identical to those reported previously. 21, 25.17, 26.79, 36.63, 47.81, 64.29, 81.45, 82.89, 85.60, 86.20, 93.42, 99.69, 113.25, 127.76, 129.86, 133.08, 133.13, 135.27, 141.14, 155.67, 165.60 . 22, 25.40, 26.81, 27.15, 29.68, 37.56, 47.99, 64.02, 81.51, 82.77, 85.52, 85.82, 93.16, 99.54, 113.28, 127.77, 129.86, 135.61, 141.38, 155.42, 165.43 .
(5′S)-4-Amino-1-{2-[6-(tert-butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-tetrahydro-furo-[3,4-d][1,3]-dioxol-4-yl]-isoxazolidin-5-yl}-1H-pyrimidine-2-one (6d
General procedure for hydrolysis of homochiral isoxazolidines 5a-d and 6a-d
The isoxazolidine 5a-d or 6a-d was dissolved in a 1.5% HCl solution in EtOH (2.5 mL), and the reaction mixture was stirred at room temperature for 3 h. The solution was brought to pH 10 by adding aqueous 10% sodium carbonate and extracted with dichloromethane (2 × 10 mL). The organic phase, dried over sodium sulfate, was filtered and evaporated to dryness. The residue was purified by radial chromatography (chloroform- 
